(Kiril, how would either you or your wife feel for the rest of your lives if YOU MADE THE WRONG CALL and your child didnt survive because of it....when you could have bought a $30 app for your smartphone that could have made the decisive call for you, and the proper advice???)
I think you're missing the point. The Wheezeometer (or App) isn't cureing asthma, if anything it only compounds Kiril's scenario and delays correct treatment.
I pose to you, what if you waiste 10minutes monitoring your child. Finally call the ambulance because the App says its a serious attack. The paramedics come and you child dies. The coronor then tells you that had the ambulance been 5minutes earlier they would have survived.
Ofcourse you'd blame the ambulance for taking 20mins. It can't be the Apps fault.
You're a chance to succeed. No doubt about that. But onshow has highlighted the lack of sales in the past. Reversing the past isn't a simple exercise. Then the patent expires anyway.
Its a speck stock, so these 'issues' are expected but they shouldn't be glossed over or ignored. Or worse treat posters with no respect because they have a negative point to make and discuss...not aimed at you.
- Forums
- ASX - By Stock
- ISN
- m thomas committed director
m thomas committed director, page-81
-
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ISN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online